NORTH CHICAGO, Ill., Sept. 30, 2024 /PRNewswire/ — U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has earned an NIH fast-track grant for the development of a novel treatment for a deadly form of brain cancer. The $500,000 award for Year 1 of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.